EU court rejects cities' bid to curb car emissions


By Reuters Staff

BRUSSELS (Reuters) - The European Union's top court dismissed a complaint on Thursday brought by the cities of Brussels, Madrid and Paris against the European Commission in which they accused it of setting car emissions limits for nitrogen oxides too high.

The Court of Justice of the European Union (CJEU) thereby overruled an earlier judgement in favour of the cities from the General Court, the EU's second-highest chamber, which prompted an appeal by Germany, Hungary and the Commission.

The case revolves around the Commission's introduction after the 2015 Dieselgate scandal of real driving emissions testing to complement laboratory procedures and its setting of emission limits on nitrogen oxides for light passenger and commercial vehicles.

The cities complained that the limits were higher those of the "Euro 6" standard that applies to light vehicles registered since 2015. As such, they argued, it undermined their abilities to regulate the circulation of vehicles to reduce air pollution.

The General Court backed their view, as did the advocate-general in his advice to the CJEU judges. However, they overturned the General Court's ruling.

The CJEU found that the Commission's directive concerned only registration and sale of vehicles and not their circulation on roads, so the cities were not directly concerned by the legislation.

However, the higher court said the cities could still limit circulation of vehicles to protect the environment without infringing EU law.

Related Articles

UPDATE 1-U.S. suicide hotline 988 is set to go live, but many states may not be ready

(Adds Lifeline calls in Washington and Wyoming, paragraph 10) By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a Read More »

COLUMN-A quiet experiment is testing broader privatization of U.S. Medicare

(The opinions expressed here are those of the author, a columnist for Reuters.) By Mark Miller (Reuters) - Millions of retirees have opted out of traditional Medicare over the past two decades, Read More »

EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 Read More »